Publication | Open Access
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)
63
Citations
31
References
2014
Year
Delayed-release DMF improved clinical and neuroradiological outcomes relative to placebo in newly diagnosed RRMS patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1